Skip to main content

Table 1 Cardiovascular risk factors

From: Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment

 

Control individuals (n = 87)

Corticosteroids (-)

Corticosteroids (+)

  

Active BD (n = 20)

Stable or inactive BD (n = 33)

Active BD (n = 19)

Stable or inactive BD (n = 15)

Males/females (n)

58/32

13/7

22/11

14/5

9/6

Age (years)

40.1 ± 1.2

40.9 ± 2.5

40.6 ± 1.5

38.4 ± 2.5

37.6 ± 2.9

Hypertension (n [%])

13 (14.9)

2 (10.1)

3 (9.4)

5 (26.3)

3 (20.0)

Smokers (n [%])

40 (46)

12 (60.0)

18 (54.4)

13 (68.4)

5 (33.3)

BMI (kg/m2)

27.2 ± 0.7

23.5 ± 1.3

25.2 ± 0.6

24.7 ± 1.0

23.4 ± 1.1

Total cholesterol (mg/dl)

193.2 ± 5.3

200.7 ± 16.0

202.7 ± 8.3

209.6 ± 14.1

215.4 ± 12.2

LDL-cholesterol (mg/dl)

132.4 ± 4.5

120.1 ± 15.1

132.2 ± 7.8

134.6 ± 4.9

143.5 ± 11.2

HDL-cholesterol (mg/dl)

47.7 ± 1.4

44.7 ± 5.5

46.8 ± 2.5

52.1 ± 4.5

52.4 ± 4.1

Triglycerides (mg/dl)

106.6 ± 9.9

115.5 ± 32.2

124.1 ± 12.5

133.2 ± 25.3

125.4 ± 22.8

Glucose (mg/dl)

85.3 ± 1.5

94.1 ± 4.4

91.3 ± 2.0

89.9 ± 3.7

84.5 ± 3.5

  1. Shown are cardiovascular risk factors in control individuals and in patients with Behçet's disease (BD) divided according to the receipt (+) or nonreceipt (-) of corticosteroid treatment and the clinical disease status. Unless otherwise stated, values are expressed as mean ± standard error. BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.